Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The company’s Intelligent Fingerprinting Drug Testing Solution is revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. This highly accurate, hygienic, and cost-effective system screens for recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries.
Intelligent Bio Solutions has over 450 accounts across 27 countries. Its Drug Testing Solution is currently being utilized across multiple industries, including construction, mining, manufacturing and engineering, transport and logistics, drug treatment, law enforcement, and forensics. INBS is advancing its FDA 510(k) regulatory pathway toward planned entry into the multi-billion-dollar US drug screening market, with recent milestones including successful penetration testing with no major vulnerabilities identified, implementation of additional security upgrades, and completion of a clinical Cut-off Study to strengthen its upcoming submission.
INBS has initiated the second phase of its clinical study program. This includes an Interference Study and a multi-site Method Comparison Study, designed to validate the system’s accuracy, usability, and workplace performance when operated by intended end users at several clinical sites.
Learn More